Skip to content

Astrana Health ASTH Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period Value Release Of Hold Back Shares

Other financials

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total equity$800.3M+7.4%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation

See full
Market cap$2.1B-3.0%

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%
FCF margin4.6%

Returns & leverage

See full
Return on equity3.9%
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Where this comes from

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Astrana Health's noncontrolling interest decrease from distributions to noncontrolling interest holders and stock repurchased during period value release of hold back shares?
Astrana Health (ASTH) reported noncontrolling interest decrease from distributions to noncontrolling interest holders and stock repurchased during period value release of hold back shares of $104K in Q1 2026.
How has Astrana Health's noncontrolling interest decrease from distributions to noncontrolling interest holders and stock repurchased during period value release of hold back shares changed year-over-year?
Astrana Health's noncontrolling interest decrease from distributions to noncontrolling interest holders and stock repurchased during period value release of hold back shares increased by 100.5% year-over-year, from -$21.84M to $104K.